Gemcitabine showed anti-cancer effect by down-regulating NK cells function via inhibition of ADAM10 expression and shedding of sULBP2, which broadens our previous understanding of gemcitabine in the treatment of pancreatic cancer. The gene discussed is ADAM10; the disease is familial pancreatic carcinoma.